TABLE 1.
Clinical information of 40 C. difficile ST2 isolate.
| Patient characteristics | N = 40 |
| Demographics | |
| Age [mean, median (range)] (year)a | 51.0 (3–95) |
| Gendera Male [n (%)] | 17 (42.5%) |
| Isolation place [n (%)] | |
| China | |
| Zhejiang | 18 (45.0%) |
| Hubei | 10 (25.0%) |
| Hunan | 2 (5.0%) |
| Hong Kong | 2 (5.0%) |
| Japan | 1 (2.5%) |
| South Korea | 1 (2.5%) |
| Singapore | 3 (7.5%) |
| Australia | 3 (7.5%) |
| Isolation place [n (%)] | |
| 2011–2013 | 12 (30.0%) |
| 2014 | 18 (45.0%) |
| 2015–2017 | 10 (25.0%) |
| Ward type [n (%)] | |
| Gastroenterology | 13 (32.5%) |
| Infectious disease | 4 (10.0%) |
| Oncology | 3 (7.5%) |
| Respiratory | 2 (5.0%) |
| Neurology | 2 (5.0%) |
| Hematology | 2 (5.0%) |
| Geriatrics | 1 (2.5%) |
| Urology | 1 (2.5%) |
| Outpatient | 2 (5.0%) |
| Health Checkup | 5 (12.5%) |
aInformation from five strains in Hong Kong and Singapore was not available.